Zilu Chen

1.0k total citations · 1 hit paper
25 papers, 774 citations indexed

About

Zilu Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zilu Chen has authored 25 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Zilu Chen's work include Cancer-related molecular mechanisms research (4 papers), Fibroblast Growth Factor Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Zilu Chen is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Fibroblast Growth Factor Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Zilu Chen collaborates with scholars based in China, United States and Canada. Zilu Chen's co-authors include Xuejun Sun, Junhui Yu, Jianbao Zheng, Jing Guo, Yunhua Wu, Kai Wang, Shan Li, Jie Qi, Xiaokun Li and Longwei Zhao and has published in prestigious journals such as ACS Nano, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Zilu Chen

23 papers receiving 770 citations

Hit Papers

Cleavage of GSDME by caspase-3 determines lobaplatin-indu... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
    2019 383 citations Junhui Yu, Shan Li et al. Cell Death and Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zilu Chen China 12 562 172 143 128 113 25 774
Chenying Zeng China 14 755 1.3× 218 1.3× 117 0.8× 162 1.3× 222 2.0× 30 1.0k
Lianwen Yuan China 13 716 1.3× 184 1.1× 98 0.7× 194 1.5× 170 1.5× 28 1.0k
Claudia Meyer Germany 9 413 0.7× 112 0.7× 298 2.1× 82 0.6× 225 2.0× 13 708
Guang‐Yu Lian China 14 433 0.8× 295 1.7× 80 0.6× 61 0.5× 233 2.1× 22 836
Ganglei Liu China 10 455 0.8× 152 0.9× 74 0.5× 59 0.5× 90 0.8× 19 663
Jun Shi China 16 560 1.0× 70 0.4× 68 0.5× 93 0.7× 306 2.7× 39 817
Zhenghao Deng China 14 482 0.9× 157 0.9× 119 0.8× 35 0.3× 239 2.1× 43 754
Jing Xiong China 19 538 1.0× 139 0.8× 163 1.1× 37 0.3× 298 2.6× 48 918
Fajuan Cheng China 16 220 0.4× 164 1.0× 82 0.6× 138 1.1× 52 0.5× 33 561
Siyuan Yan China 15 366 0.7× 68 0.4× 63 0.4× 43 0.3× 184 1.6× 33 606

Countries citing papers authored by Zilu Chen

Since Specialization
Citations

This map shows the geographic impact of Zilu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zilu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zilu Chen more than expected).

Fields of papers citing papers by Zilu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zilu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zilu Chen. The network helps show where Zilu Chen may publish in the future.

Co-authorship network of co-authors of Zilu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zilu Chen. A scholar is included among the top collaborators of Zilu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zilu Chen. Zilu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Chunhong, Dandan Liu, Zilu Chen, et al.. (2025). Immune cells mediate the association between the plasma lipidome and pancreatic cancer: a Mendelian randomization analysis. Scientific Reports. 15(1). 24451–24451.
3.
Sun, Xuejun, Wei Wang, Zilu Chen, et al.. (2024). Innovative Oral Nano/Gene Delivery System Based on Engineered Modified Saccharomyces cerevisiae for Colorectal Cancer Therapy. ACS Nano. 18(41). 28212–28227. 6 indexed citations
4.
Chen, Zilu, et al.. (2023). The role of intestinal immune cells and matrix metalloproteinases in inflammatory bowel disease. Frontiers in Immunology. 13. 1067950–1067950. 14 indexed citations
5.
Zhang, Qin, et al.. (2023). 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis. Cancer Gene Therapy. 30(10). 1414–1425. 16 indexed citations
6.
Zhu, Lin, Jing Shi, Zilu Chen, et al.. (2023). Naringin Inhibits the Proliferation, Migration, Invasion and Epithelial-to-Mesenchymal Transition of Gastric Cancer Cells via the PI3K/AKT Signaling Pathway.. PubMed. 29(1). 191–197. 5 indexed citations
7.
Zhang, Qin, et al.. (2023). USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A. Cell Death and Differentiation. 30(11). 2393–2407. 24 indexed citations
8.
Yuan, Xiaofei, Yanfei Li, Zilu Chen, et al.. (2023). Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma. BMC Cancer. 23(1). 1217–1217. 2 indexed citations
9.
Qu, Xiaoyan, Zilu Chen, Lizhong Zeng, et al.. (2023). A bionic “Trojan horse”-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy. Journal of Controlled Release. 358. 204–218. 23 indexed citations
10.
Chen, Zilu, et al.. (2023). Triphenyl phosphate exposure impairs colorectal health by altering host immunity and colorectal microbiota. Chemosphere. 349. 140905–140905. 2 indexed citations
11.
Chen, Zilu, Fangfang Zeng, Xiaolan Jiang, et al.. (2023). Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma. BMC Cancer. 23(1). 1146–1146. 8 indexed citations
12.
Li, Wanxia, Chao Yang, Feipeng Zhao, et al.. (2022). Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective study. BMC Cancer. 22(1). 1262–1262. 4 indexed citations
13.
Guo, Jing, Junhui Yu, Zilu Chen, et al.. (2022). DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR. Cell Cycle. 21(20). 2165–2178. 3 indexed citations
14.
Guo, Jing, Jianbao Zheng, Zilu Chen, et al.. (2021). GW4064 enhances the chemosensitivity of colorectal cancer to oxaliplatin by inducing pyroptosis. Biochemical and Biophysical Research Communications. 548. 60–66. 56 indexed citations
15.
Xu, Zhengshui, Jianbao Zheng, Zilu Chen, et al.. (2021). Multilevel regulation of Wnt signaling by Zic2 in colon cancer due to mutation of β-catenin. Cell Death and Disease. 12(6). 584–584. 14 indexed citations
16.
Wu, Yunhua, Guangbing Wei, Junhui Yu, et al.. (2019). Danhong Injection Alleviates Postoperative Intra-abdominal Adhesion in a Rat Model. Oxidative Medicine and Cellular Longevity. 2019. 1–11. 25 indexed citations
17.
Yu, Junhui, Shan Li, Jie Qi, et al.. (2019). Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death and Disease. 10(3). 193–193. 383 indexed citations breakdown →
18.
Liang, Guang, Lintao Song, Zilu Chen, et al.. (2017). Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney International. 93(1). 95–109. 124 indexed citations
19.
20.
Zhao, Longwei, et al.. (2017). Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice. BMC Biotechnology. 17(1). 58–58. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chenying Zeng Breakdown of academic impact, for papers by Lianwen Yuan Breakdown of academic impact, for papers by Claudia Meyer Breakdown of academic impact, for papers by Guang‐Yu Lian Breakdown of academic impact, for papers by Ganglei Liu Breakdown of academic impact, for papers by Jun Shi Breakdown of academic impact, for papers by Zhenghao Deng Breakdown of academic impact, for papers by Jing Xiong Breakdown of academic impact, for papers by Fajuan Cheng Breakdown of academic impact, for papers by Siyuan Yan
Rankless by CCL
2026